Investigación

Mayo Clinic ophthalmologists and ENT specialists collaborate to produce the best possible outcomes.

In Mayo Clinic's Department of Ophthalmology, care providers and scientists are dedicated to finding better options for people with vision impairments. Physician-scientists conduct a wide variety of research strategies across a spectrum of eye conditions to ensure patients have access to the latest, most-effective treatments available.

Eye specialists in the Department of Ophthalmology are involved at every level of research. In the lab, researchers detail the precise physiology of both normal eye functions and eye and vision diseases. They look at how cells function in each and how genes regulate them.

At the translational level, researchers seek to improve treatments, both surgical and nonsurgical. They do so by developing new drugs and analyzing best methods for surgical and transplant procedures.

When a promising treatment is ready to be introduced to the patient, Mayo Clinic researchers conduct clinical trials to measure the new treatment's effectiveness.

A key advantage of Mayo Clinic's ophthalmology research efforts is the scientist's access to vital infrastructure and specialists. For instance, ophthalmology researchers can work with biostatisticians and epidemiologists to leverage Mayo Clinic's extensive medical record-keeping system. Together, they can conduct comprehensive, retrospective studies to better understand the natural course of eye disease, the long-term outcomes of disease treatment and trends in the frequency of eye-related illness.

Other vital infrastructures include:

Through every stage of research, Mayo Clinic researchers work with colleagues and institutions throughout the country and the world.

The success of Mayo Clinic's ophthalmology research efforts have earned it decades-long funding from the National Institutes of Health as well as from the organization Research to Prevent Blindness and other private benefactors and foundations.

Perfiles de la investigación

Sept. 04, 2021